CompletedNCT06717724
§ Procaine Periarticular Injections for Pain Reduction in Elderly With Osteoarthritis
Medication studyAges 65+RomaniaDepression
Understand this study
Who was this study for?
Listed age limits: from 65 years.
- Listed locations
- BucharestSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: February 8, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 203
- Sponsor
- Sf Luca Chronic Disease Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Romania
- Age range
- Over 65 Years
- Official registry ID
- NCT06717724
- Official title
Show the full official title
Complementary Treatment With Procaine Periarticular Injections for Pain Reduction and Functional Improvement in Elderly Individuals With Osteoarthritis
Get this study by email
Recruitment & locations
CompletedBucharest
Questions about this study
Who is behind this study?
The study sponsor is Sf Luca Chronic Disease Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Periarticular Procaine Injection (PAPI).
Who was this study for?
Listed age limits: from 65 years.
Want to explore more studies?
Explore studiesRelated studies
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Lu AA21004 in Patients with Major Depressive Disorder
A randomized, double-blind study comparing the efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder